Story · Medicine & Biotech
Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 use
2 outlets · first reported by Medical Xpress on · latest · 32 hours of coverage
Medicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate… (Medical Xpress)
Coverage, in order
-
Ending Medicaid coverage for weight-loss drugs linked to sharp drop in GLP-1 useMedicaid prescriptions for weight loss–approved GLP-1 medications fell sharply after four states ended coverage of the drugs, according to a new study led by researchers at the University of Pittsburgh. The findings, published in JAMA, demonstrate how state coverage decisions can have an immediate…
-
Changes in Medicaid GLP-1 Prescription Dispensing After 4 States Ended Weight-Management Coverage
On January 1, 2026, California, New Hampshire, Pennsylvania, and South Carolina ended Medicaid coverage of GLP-1s indicated for weight management. In 2025 Q4 these four states accounted for 60.5% of Medicaid weight-management GLP-1 prescriptions nationally (661,478 of 1,094,191). We used State Drug…
-
GLP-1 weight-loss drugs linked to inadequate intake of key nutrients in some peopleDrugs taken to suppress appetite, such as Wegovy and Mounjaro, are associated with inadequate intakes of key nutrients and energy in some people, finds a small exploratory study published in the journal BMJ Nutrition Prevention & Health.
Alivewire groups outlets reporting the same story. Each headline links to the outlet that wrote it; nothing is republished here.